US 12319744
Treatment and prevention of hemophilic arthropathy with an antibody against endothelial cell protein C receptor (EPCR)
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 12319744 (Treatment and prevention of hemophilic arthropathy with an antibody against endothelial cell protein C receptor (EPCR)) held by The Board of Regents of the University of Texas System expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K38/4846, A61K9/0019